Evidence map›Paper›PMID 31454413›Full record

ArticleBritish journal of pharmacology2019

Δ

Zheng-Xiong Xi, Pretal Muldoon, Xiao-Fei Wang, Guo-Hua Bi, M Imad Damaj, Aron H Lichtman, Roger G Pertwee, Eliot L Gardner

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. ΔBritish journal of pharmacology · 2019
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Zheng-Xiong XiMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.ORCID 0000-0001-6482-8104
Pretal MuldoonDepartment of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Xiao-Fei WangState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
Guo-Hua BiMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
M Imad DamajDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Aron H LichtmanDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Roger G PertweeInstitute of Medical Sciences, University of Aberdeen, Aberdeen, UK.ORCID 0000-0003-3227-2783
Eliot L GardnerMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.ORCID 0000-0003-1541-3249
National Institute on Drug Abuse · USVirginia Commonwealth University · USUniversity of Aberdeen · GB

Funding

VCU Center for Drug Addiction ResearchP30DA033934 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAMID I AKBARALI · 2014 to 2026
$13.8M
THE ROLE OF ENDOGENOUS OPIOIDS IN SUDDEN INFANT DEATHP50DA005274 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ABOOD, MARY E · 1988 to 2011
$12.6M
Endocannabinoid brain mechanisms and addictionZIADA000513 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI GARDNER, ELIOT · 2009 to 2020
$6.0M
G PROTEINS AND OPIOID RECEPTOR FUNCTIONSK05DA000513 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LAW, PING-YEE · 2001 to 2010
$1.2M
Intramural NIH HHS ZIA DA000513NIDA NIH HHS K05 DA000513NIDA NIH HHS P30 DA033934NIDA NIH HHS P50 DA005274NIDA NIH HHS ZIA DA000513
6 · The paper itself

Abstract

background and purposeBoth types of cannabinoid receptors-CB EXPERIMENTAL APPROACH: We tested Δ KEY

resultsΔ CONCLUSIONS AND IMPLICATIONS: We conclude that Δ

Indexed as

AnimalsDisease Models, AnimalDrug-Seeking BehaviorHyperalgesiaMiceNicotineRatsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Self AdministrationSmoking Cessation AgentsSubstance Withdrawal SyndromeTobacco Use DisorderNicotineReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Smoking Cessation Agents

Identifiers

PMID31454413
PMCPMC6965695
OpenAlexW2970154925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.